logo

Pacira Pharmaceuticals, Inc. (PCRX)



Trade PCRX now with
  Date
  Headline
4/9/2018 4:08:43 PM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) FY18 Rev. Estimate To 314.7 M From 309.1 M
4/9/2018 4:08:27 PM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) Q2 18 Rev. Estimate To 79.2 M From 77.8 M
4/9/2018 4:07:26 PM Wedbush Is Increasing Pacira Pharmaceuticals, Inc. (PCRX) FY18 Estimate To -0.92 From -1.33
4/9/2018 4:07:11 PM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) Q1 18 Estimate To -0.22 From -0.30
4/9/2018 4:06:50 PM Wedbush Reiterates Pacira Pharmaceuticals, Inc. (PCRX) At Outperform With $80 Up From $72 Price Target
4/9/2018 9:58:32 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) 4Q19 Estimate To 1.17 From 0.29
4/9/2018 9:58:21 AM Wedbush Is Lowering Pacira Pharmaceuticals, Inc. (PCRX) 3Q19 Estimate To -0.03 From -0.01
4/9/2018 9:58:07 AM Wedbush Is Cutting Pacira Pharmaceuticals, Inc. (PCRX) 2Q19 Estimate To -0.55 From -0.14
4/9/2018 9:57:58 AM Wedbush Is Cutting Pacira Pharmaceuticals, Inc. (PCRX) 1Q19 Estimate To -0.58 From -0.15
4/9/2018 9:57:47 AM Wedbush Is Cutting Pacira Pharmaceuticals, Inc. (PCRX) 2018 Estimate To -0.08 From -0.03
4/9/2018 9:57:35 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) 4Q18 Estimate To 0.97 From 0.24
4/9/2018 9:57:24 AM Wedbush Is Cutting Pacira Pharmaceuticals, Inc. (PCRX) 3Q18 Estimate To -0.08 From -0.02
4/9/2018 9:57:12 AM Wedbush Is Lowering Pacira Pharmaceuticals, Inc. (PCRX) 2Q18 Estimate To -0.56 From -0.14
2/28/2018 8:16:19 AM Pacira Pharma Q4 Total Revenues $79.1 Mln, 8% Increase